An emerging category of laboratory tests may help improve care and treatment outcomes for cancer patients, according to a recent survey by the nonprofit CancerCare, but insurers and employers do not ...

Medicare Part B covers various genetic tests for diagnosing genetic conditions, identifying cancer risks, and predicting medication responses if a doctor deems them medically necessary. The cost of ...

Three years ago, New York state took a huge step forward by expanding access to biomarker testing, which is said to be a game changer in cancer care. Now, however, advocates fear the state could be ...